CORBF
Price
$0.55
Change
-$0.00 (-0.00%)
Updated
Aug 13 closing price
Capitalization
200.87M
MBOT
Price
$3.09
Change
-$0.04 (-1.28%)
Updated
Aug 15 closing price
Capitalization
140.74M
83 days until earnings call
Interact to see
Advertisement

CORBF vs MBOT

Header iconCORBF vs MBOT Comparison
Open Charts CORBF vs MBOTBanner chart's image
Global Cord Blood
Price$0.55
Change-$0.00 (-0.00%)
Volume$3.82K
Capitalization200.87M
Microbot Medical
Price$3.09
Change-$0.04 (-1.28%)
Volume$1.73M
Capitalization140.74M
CORBF vs MBOT Comparison Chart in %
Loading...
CORBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CORBF vs. MBOT commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CORBF is a Hold and MBOT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (CORBF: $0.55 vs. MBOT: $3.09)
Brand notoriety: CORBF and MBOT are both not notable
CORBF represents the Medical Specialties, while MBOT is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CORBF: 28% vs. MBOT: 113%
Market capitalization -- CORBF: $200.87M vs. MBOT: $140.74M
CORBF [@Medical Specialties] is valued at $200.87M. MBOT’s [@Pharmaceuticals: Other] market capitalization is $140.74M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.48B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CORBF’s FA Score shows that 1 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • CORBF’s FA Score: 1 green, 4 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, CORBF is a better buy in the long-term than MBOT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CORBF’s TA Score shows that 1 TA indicator(s) are bullish while MBOT’s TA Score has 6 bullish TA indicator(s).

  • CORBF’s TA Score: 1 bullish, 7 bearish.
  • MBOT’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MBOT is a better buy in the short-term than CORBF.

Price Growth

CORBF (@Medical Specialties) experienced а -59.26% price change this week, while MBOT (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +3.75%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +1.62%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.53%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +4.24%.

Reported Earning Dates

MBOT is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Medical Specialties (+3.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (+0.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CORBF($201M) has a higher market cap than MBOT($141M). MBOT YTD gains are higher at: 175.893 vs. CORBF (-63.333).
CORBFMBOTCORBF / MBOT
Capitalization201M141M143%
EBITDAN/A-12.18M-
Gain YTD-63.333175.893-36%
P/E Ratio3.03N/A-
RevenueN/A0-
Total CashN/A30.4M-
Total DebtN/A138K-
FUNDAMENTALS RATINGS
CORBF vs MBOT: Fundamental Ratings
CORBF
MBOT
OUTLOOK RATING
1..100
3812
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6397
PRICE GROWTH RATING
1..100
9536
P/E GROWTH RATING
1..100
25100
SEASONALITY SCORE
1..100
n/a29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBOT's Valuation (57) in the Biotechnology industry is in the same range as CORBF (58) in the Medical Or Nursing Services industry. This means that MBOT’s stock grew similarly to CORBF’s over the last 12 months.

MBOT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CORBF (100) in the Medical Or Nursing Services industry. This means that MBOT’s stock grew similarly to CORBF’s over the last 12 months.

CORBF's SMR Rating (63) in the Medical Or Nursing Services industry is somewhat better than the same rating for MBOT (97) in the Biotechnology industry. This means that CORBF’s stock grew somewhat faster than MBOT’s over the last 12 months.

MBOT's Price Growth Rating (36) in the Biotechnology industry is somewhat better than the same rating for CORBF (95) in the Medical Or Nursing Services industry. This means that MBOT’s stock grew somewhat faster than CORBF’s over the last 12 months.

CORBF's P/E Growth Rating (25) in the Medical Or Nursing Services industry is significantly better than the same rating for MBOT (100) in the Biotechnology industry. This means that CORBF’s stock grew significantly faster than MBOT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORBFMBOT
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
72%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
74%
Declines
ODDS (%)
N/A
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
CORBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MBOT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GMOWX18.94N/A
N/A
GMO Resources VI
RYVAX171.07N/A
N/A
Rydex Energy Services H
OFAFX27.77N/A
N/A
Olstein All Cap Value Adv
FIQWX17.75N/A
N/A
Fidelity Advisor Strategic Div & Inc Z
TEOOX10.02N/A
N/A
Transamerica Emerging Markets Eq R6

CORBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORBF has been loosely correlated with SINT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CORBF jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORBF
1D Price
Change %
CORBF100%
N/A
SINT - CORBF
38%
Loosely correlated
-0.33%
APYX - CORBF
36%
Loosely correlated
+1.89%
MBOT - CORBF
33%
Loosely correlated
-1.28%
QTRX - CORBF
30%
Poorly correlated
+0.66%
BVS - CORBF
30%
Poorly correlated
+0.41%
More